Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Conditions
- Cutaneous Squamous Cell Carcinoma
- Skin Cancer
Interventions
- DRUG: Cosibelimab
- DRUG: Prednisone
- DRUG: Sirolimus
- DRUG: Everolimus
Sponsor
Dana-Farber Cancer Institute
Collaborators